Call for Papers   a href="https://bentham.manuscriptpoint.com/journals/acamc" class="submit_manuscript">Call for Papers  

Article Details


Preparation and Preliminary Evaluation of <sup>68</sup>Ga-Acridine: An Attempt to Study the Potential of Radiolabeled DNA Intercalator as a PET Radiotracer for Tumor Imaging

[ Vol. 20 , Issue. 13 ]

Author(s):

Subhajit Ghosh, Tapas Das*, Shishu K. Suman, Haladhar D. Sarma and Ashutosh Dash   Pages 1538 - 1547 ( 10 )

Abstract:


<P>Introduction: Acridine is a well-known DNA intercalator and thereby gets easily inserted within DNA. As uncontrolled rapid cell division is one of the primary characteristics of the tumors, it is expected that acridine or its suitable derivatives will have preferential accumulation in the tumorous lesions. Therefore, an attempt was made to radiolabel an acridine derivative with <sup>68</sup>Ga and study the potential of the <sup>68</sup>Ga-acridine complex as a PET agent for tumor imaging. </P><P> Methods: 9-aminoacridine was coupled with p-NCS-benzyl-DOTA to render it suitable for labeling with <sup>68</sup>Ga. The purified acridine-DOTA conjugate was radiolabeled with <sup>68</sup>Ga, eluted from a <sup>68</sup>Ge/<sup>68</sup>Ga radionuclide generator. Various radiolabeling parameters were optimized and the stability of the radiolabeled preparation was studied. The biological behavior of the <sup>68</sup>Ga-acridine complex was studied both in vitro and in vivo using Raji cell line and fibrosarcoma tumor bearing Swiss mice, respectively. </P><P> Results: <sup>68</sup>Ga-acridine complex was obtained with ~100% radiochemical purity under the optimized reaction conditions involving incubation of 2mg/mL of ligand at 100°C for 30 minutes. The complex maintained a radiochemical purity of >95% in normal saline and >65% in human blood serum at 3h post-incubation. In vitro cellular study showed (3.2±0.1)% uptake of the radiotracer in the Raji cells. Biodistribution study revealed significant tumor accumulation [(11.41±0.41)% injected activity in per gram] of the radiotracer within 1h postadministration along with uptake in other non-target organs such as, blood, liver, GIT kidney etc. </P><P> Conclusion: The present study indicates the potential of <sup>68</sup>Ga-acridine as a PET agent for imaging of tumorous lesions. However, further detailed evaluation of the agent is warranted to explore its actual potential.</P>

Keywords:

Radiolabeled DNA intercalator, <sup>68</sup>Ga-acridine, PET radiotracer, tumor imaging, fibrosarcoma, acridine-DOTA conjugate.

Affiliation:

Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai-400085, Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai-400085, Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai-400085, Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Trombay, Mumbai-400085, Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai-400085

Graphical Abstract:



Read Full-Text article